Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China

INTRODUCTION: Once-daily and once-weekly injectable glucagon-like peptide-1 receptor agonist therapies (GLP-1 RAs) are established in obesity and type 2 diabetes mellitus (T2DM). In T2DM, both once-daily and once-weekly insulin are expected to be available. This study elicited utilities associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: McEwan, Phil, Baker-Knight, James, Ásbjörnsdóttir, Björg, Yi, Yunni, Fox, Aimee, Wyn, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080344/
https://www.ncbi.nlm.nih.gov/pubmed/35526173
http://dx.doi.org/10.1007/s10198-022-01470-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080344/
https://www.ncbi.nlm.nih.gov/pubmed/35526173
http://dx.doi.org/10.1007/s10198-022-01470-w

Ejemplares similares